Freddie Hamdy
Freddie C. Hamdy joined the University of Oxford in 2008 as Nuffield Professor of Surgery and Head of the Nuffield Department of Surgical Sciences, Professor of Urology, and Honorary Consultant Urological Surgeon, as well as Fellow of Balliol College. He trained in Surgery and Urology at Liverpool, Sheffield and Newcastle, and was founding chair of Urology, Director of the Section of Oncology and of the Division of Clinical Sciences at Sheffield. He introduced a robot-assisted surgical programme to Oxford in 2009, led the Oxford NIHR BRC (Biomedical Research Centre) Surgical Innovation and Evaluation Theme, and was founding co-Director of the first Surgical Intervention Trials Unit at Oxford in the UK. His research activities include clinical, translational and basic science programmes on the biology of urological malignancies. He is Chief Investigator of many studies including the HTA NIHR ProtecT trial on prostate cancer, the largest of its kind which changed clinical practice worldwide, and conducted a pioneering first-in-man trial of image-guided surgery in prostate cancer using molecularly targeted fluorescence. He was Director of the Division of Surgery, Women’s and Oncology at the Oxford University Hospitals NHS Foundation Trust between 2010-2020. He has raised over £80 million in peer-reviewed research income, and published over 500 peer-reviewed manuscripts. He was elected Fellow of the Academy of Medical Sciences in 2007, NIHR Senior Investigator in 2010, and became Editor-in-Chief of the British Journal of Urology International in 2020. He was appointed CBE by HM King Charles in 2024 for services to surgical and cancer sciences.
16th August 2025
| Time | Session |
|---|---|
|
08:30
10:00
|
TICC - 3F Banquet Hall
|
|
13:30
17:00
|
TICC - 1F 101A
|